129 related articles for article (PubMed ID: 1839138)
1. Changes in brain striatum dopamine and acetylcholine receptors induced by chronic CDP-choline treatment of aging mice.
Giménez R; Raïch J; Aguilar J
Br J Pharmacol; 1991 Nov; 104(3):575-8. PubMed ID: 1839138
[TBL] [Abstract][Full Text] [Related]
2. Effect of repeated administration of manganese on the striatal cholinergic and dopaminergic receptors in the rat.
Bhargava HN
Toxicol Lett; 1987 Jul; 37(2):135-41. PubMed ID: 3603588
[TBL] [Abstract][Full Text] [Related]
3. An enhanced sensitivity of muscarinic cholinergic receptor associated with dopaminergic receptor subsensitivity after chronic antidepressant treatment.
Koide T; Matsushita H
Life Sci; 1981 Mar; 28(10):1139-45. PubMed ID: 7231043
[No Abstract] [Full Text] [Related]
4. Effect of long-term L-dopa administration on the dopaminergic and cholinergic (muscarinic) receptors of striatum in 6-hydroxydopamine lesioned rats.
Suga M
Life Sci; 1980 Sep; 27(10):877-82. PubMed ID: 7412476
[No Abstract] [Full Text] [Related]
5. Decrease in the number of rat brain dopamine and muscarinic receptors after chronic alcohol intake.
Syvälahti EK; Hietala J; Röyttä M; Grönroos J
Pharmacol Toxicol; 1988 Apr; 62(4):210-2. PubMed ID: 3387375
[TBL] [Abstract][Full Text] [Related]
6. Partial protection by CDP-choline against kainic acid-induced lesion in the rat caudate nucleus.
Porceddu ML; Concas A
Farmaco Sci; 1985 Aug; 40(8):617-22. PubMed ID: 4043378
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic administration of haloperidol (intermittently) and haloperidol-decanoate (continuously) on D2 dopamine and muscarinic cholinergic receptors and on carbachol-stimulated phosphoinositide hydrolysis in the rat striatum.
Akiyama K; Sato M; Yamada N; Otsuki S
Jpn J Psychiatry Neurol; 1987 Jun; 41(2):311-20. PubMed ID: 2830427
[TBL] [Abstract][Full Text] [Related]
8. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
[TBL] [Abstract][Full Text] [Related]
9. [3H]spiperone and [3H]quinuclidinyl benzilate binding in striatal membranes from rats chronically treated with manganese chloride throughout development and for over two years.
Leung TK; Lai JC; Lim L
Gen Pharmacol; 1986; 17(1):121-3. PubMed ID: 3949146
[TBL] [Abstract][Full Text] [Related]
10. Peripheral administration of CDP-choline and its cholinergic metabolites increases serum insulin: muscarinic and nicotinic acetylcholine receptors are both involved in their actions.
Ilcol YO; Cansev M; Yilmaz MS; Hamurtekin E; Ulus IH
Neurosci Lett; 2008 Jan; 431(1):71-6. PubMed ID: 18162319
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute and subacute administration of bicuculline on dopamine and muscarinic receptors in rat brain.
Lim DK; Ito Y; Hoskins B; Ho IK
Brain Res Bull; 1988 Jul; 21(1):21-4. PubMed ID: 3064880
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic regulation of muscarinic receptor binding in the corpus striatum.
Ehlert FJ; Roeske WR; Yamamura HI
Proc West Pharmacol Soc; 1981; 24():93-5. PubMed ID: 7255494
[No Abstract] [Full Text] [Related]
13. Effects of CDP-choline on striatal dopamine level and behavior in rats.
Shibuya M; Kageyama N; Taniguchi T; Hidaka H; Fujiwara M
Jpn J Pharmacol; 1981 Feb; 31(1):47-52. PubMed ID: 7253343
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic and dopaminergic alterations in the mouse central nervous system following acute trimethyltin exposure.
Ali SF; Slikker W; Newport GD; Goad PT
Acta Pharmacol Toxicol (Copenh); 1986 Sep; 59(3):179-88. PubMed ID: 2879410
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic and dopaminergic receptors in the aging human brain.
Rinne JO
Brain Res; 1987 Feb; 404(1-2):162-8. PubMed ID: 3567563
[TBL] [Abstract][Full Text] [Related]
16. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
Yamada S; Isogai M; Okudaira H; Hayashi E
J Pharmacol Exp Ther; 1983 Aug; 226(2):519-25. PubMed ID: 6875862
[TBL] [Abstract][Full Text] [Related]
17. Neurotransmitter receptors in brain regions of acrylamide- treated rats. II: Effects of extended exposure to acrylamide.
Bondy SC; Tilson HA; Agrawal AK
Pharmacol Biochem Behav; 1981 Apr; 14(4):533-7. PubMed ID: 6262843
[TBL] [Abstract][Full Text] [Related]
18. Effects of hypoxia and cytidine (5') diphosphocholine on the concentrations of dopamine, norepinephrine and metabolites in rat hypothalamus and striatum.
Saligaut C; Daoust M; Moore N; Boismare F
Arch Int Pharmacodyn Ther; 1987 Jan; 285(1):25-33. PubMed ID: 3579424
[TBL] [Abstract][Full Text] [Related]
19. Compartment-specific changes in the density of choline and dopamine uptake sites and muscarinic and dopaminergic receptors during the development of the baboon striatum: a quantitative receptor autoradiographic study.
Lowenstein PR; Slesinger PA; Singer HS; Walker LC; Casanova MF; Raskin LS; Price DL; Coyle JT
J Comp Neurol; 1989 Oct; 288(3):428-46. PubMed ID: 2794143
[TBL] [Abstract][Full Text] [Related]
20. Effects of CDP-choline administration on receptor-stimulated inositol phospholipid hydrolysis in brain slices and neuronal cultures.
Canonico PL; Nicoletti F; Sortino MA; Aleppo G; Scapagnini U
Funct Neurol; 1992; 7(4):275-81. PubMed ID: 1330841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
